Literature DB >> 27569223

MicroRNAs to take the place of collateral flow index measurements and Rentrop scoring?-Reply to Papageorgiou et al.

Nazanin Hakimzadeh1, Jan J Piek2.   

Abstract

Year:  2016        PMID: 27569223      PMCID: PMC4980374          DOI: 10.21037/atm.2016.07.26

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  12 in total

Review 1.  Effects of aging on the collateral circulation, and therapeutic implications.

Authors:  Stephen E Epstein; Roberta M Lassance-Soares; James E Faber; Mary Susan Burnett
Journal:  Circulation       Date:  2012-06-26       Impact factor: 29.690

2.  Galectin-2 expression is dependent on the rs7291467 polymorphism and acts as an inhibitor of arteriogenesis.

Authors:  Anja M van der Laan; Stephan H Schirmer; Margreet R de Vries; Jasper J Koning; Oscar L Volger; Joost O Fledderus; Antonius J N M Bastiaansen; Maurits R Hollander; Josefien M Baggen; Karel T Koch; Jan Baan; José P Henriques; René J van der Schaaf; Marije M Vis; Reina E Mebius; Tineke C van der Pouw Kraan; Paul H Quax; Jan J Piek; Anton J Horrevoets; Niels van Royen
Journal:  Eur Heart J       Date:  2011-08-10       Impact factor: 29.983

3.  The coronary collateral circulation--clinical relevances and therapeutic options.

Authors:  Pascal Meier; Christian Seiler
Journal:  Heart       Date:  2012-12-22       Impact factor: 5.994

4.  MiR423-5p as a circulating biomarker for heart failure.

Authors:  Anke J Tijsen; Esther E Creemers; Perry D Moerland; Leon J de Windt; Allard C van der Wal; Wouter E Kok; Yigal M Pinto
Journal:  Circ Res       Date:  2010-02-25       Impact factor: 17.367

5.  MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1.

Authors:  Andreas Schober; Maliheh Nazari-Jahantigh; Yuanyuan Wei; Kiril Bidzhekov; Felix Gremse; Jochen Grommes; Remco T A Megens; Kathrin Heyll; Heidi Noels; Michael Hristov; Shusheng Wang; Fabian Kiessling; Eric N Olson; Christian Weber
Journal:  Nat Med       Date:  2014-03-02       Impact factor: 53.440

6.  Clinical parameters associated with collateral development in patients with chronic total coronary occlusion.

Authors:  N W van der Hoeven; P F Teunissen; G S Werner; R Delewi; S H Schirmer; T Traupe; A M van der Laan; J G Tijssen; J J Piek; C Seiler; N van Royen
Journal:  Heart       Date:  2013-05-28       Impact factor: 5.994

7.  Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice.

Authors:  Stephan H Schirmer; Joost O Fledderus; Pieter T G Bot; Perry D Moerland; Imo E Hoefer; Jan Baan; José P S Henriques; René J van der Schaaf; Marije M Vis; Anton J G Horrevoets; Jan J Piek; Niels van Royen
Journal:  Circ Res       Date:  2008-04-17       Impact factor: 17.367

Review 8.  MicroRNAs in age-related diseases.

Authors:  Stefanie Dimmeler; Pierluigi Nicotera
Journal:  EMBO Mol Med       Date:  2013-01-22       Impact factor: 12.137

9.  Circulating MicroRNAs Characterizing Patients with Insufficient Coronary Collateral Artery Function.

Authors:  Nazanin Hakimzadeh; A Yaël Nossent; Anja M van der Laan; Stephan H Schirmer; Maurice W J de Ronde; Sara-Joan Pinto-Sietsma; Niels van Royen; Paul H A Quax; Imo E Hoefer; Jan J Piek
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

Review 10.  The future of collateral artery research.

Authors:  Nazanin Hakimzadeh; Hein J Verberne; Maria Siebes; Jan J Piek
Journal:  Curr Cardiol Rev       Date:  2014-02
View more
  2 in total

1.  Reduced Plasma miR-146a Is a Predictor of Poor Coronary Collateral Circulation in Patients with Coronary Artery Disease.

Authors:  Junnan Wang; Youyou Yan; Dandan Song; Bin Liu
Journal:  Biomed Res Int       Date:  2016-12-05       Impact factor: 3.411

2.  Monocytic microRNA profile associated with coronary collateral artery function in chronic total occlusion patients.

Authors:  Nazanin Hakimzadeh; Joëlle Elias; Gilbert W M Wijntjens; Ruud Theunissen; Angela van Weert; Martijn W Smulders; Nynke van den Akker; Perry D Moerland; Hein J Verberne; Loes P Hoebers; Jose P S Henriques; Anja M van der Laan; Mustafa Ilhan; Mark Post; Sebastiaan C A M Bekkers; Jan J Piek
Journal:  Sci Rep       Date:  2017-05-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.